Benitec Biopharma BNTC
$ 12.06
-0.9%
Quarterly report 2024-Q3
added 11-14-2024
Benitec Biopharma Financial Statements 2011-2024 | BNTC
Annual Financial Statements Benitec Biopharma
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
35.7 M | 4.09 M | 351 K | 8.59 M | 7.66 M | 8.5 M | 29.5 M | 18.9 M | 12.2 M | 75.9 M | 27.4 M | - | - | - |
Shares |
4.06 M | 1.39 M | 481 K | 4.3 M | 1.02 M | 858 K | 702 K | 585 K | 474 K | 385 K | 96.3 K | - | - | - |
Historical Prices |
8.79 | 2.95 | 0.73 | 2.32 | 3.15 | 7.77 | 27.1 | 44.2 | 40.3 | 22.6 | 190 | - | - | - |
Net Income |
-21.8 M | -19.6 M | -18.2 M | -13.9 M | -8.27 M | 2.87 M | -8.55 M | -4.37 M | -18.5 M | -8.83 M | -10.8 M | -6.42 M | - | - |
Revenue |
- | 75 K | 73 K | 59 K | 97 K | 11.3 M | 455 K | 450 K | 347 K | 829 K | 1.02 M | 546 K | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 282 K | 10.9 M | 124 K | 241 K | 243 K | 798 K | 980 K | 370 K | - | - |
Operating Income |
-22.5 M | -19.1 M | -17.9 M | -13.6 M | -8.28 M | 2.58 M | - | - | - | - | - | - | - | - |
Interest Expense |
-204 K | -30 K | -79 K | 37 K | 34 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-22.4 M | -18.9 M | -17.7 M | -13.4 M | -7.91 M | 2.69 M | -8.41 M | -4 M | -13.4 M | -7.93 M | -9.9 M | -6.64 M | - | - |
Operating Expenses |
22.5 M | 19.2 M | 17.9 M | 13.7 M | 8.56 M | 8.35 M | 8.68 M | 4.4 M | 16.2 M | 8.8 M | 11.3 M | 7.11 M | - | - |
General and Administrative Expenses |
6.99 M | 6.38 M | 6.65 M | 6.51 M | 5.57 M | 6.66 M | 6.41 M | 6.99 M | 8.96 M | 6.17 M | 7.67 M | 4.39 M | - | - |
All numbers in USD currency
Quarterly Income Statement Benitec Biopharma
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
10.6 M | 10.1 M | 2.62 M | 2.58 M | 2.16 M | 1.67 M | 1.65 M | 1.62 M | 639 K | 8.17 M | 8.17 M | 8.17 M | 8.17 M | 8.17 M | 4.75 M | 4.3 M | 1.11 M | 4.3 M | 1.11 M | 1.04 M | 859 K | 857 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-5.06 M | - | -4.28 M | -6.8 M | -5.95 M | - | -4.4 M | -5.41 M | -5.09 M | -10.5 M | -3.28 M | -4.82 M | -5.04 M | -9.87 M | -5.04 M | -3.25 M | -3.25 M | -3.25 M | -2.72 M | -2.09 M | -1.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | 54 K | 14 K | - | 14 K | 48 K | 25 K | - | 25 K | 1 K | 1 K | 55 K | 1 K | 55 K | 77 K | 33 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.79 M | - | -4.14 M | -6.93 M | -5.87 M | - | -4.34 M | -5.61 M | -4.58 M | -10.2 M | -3.46 M | -4.84 M | -4.82 M | -9.66 M | -3.79 M | -3.26 M | -2.69 M | -3.26 M | -2.69 M | -2.11 M | -1.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
35 K | - | -16 K | -16 K | -18 K | - | - | 50 K | - | 50 K | -29 K | - | 37 K | - | - | 10 K | 27 K | 10 K | 27 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-5.77 M | - | -4.12 M | -6.91 M | -5.86 M | - | -4.31 M | -5.57 M | -4.54 M | -10.1 M | -3.41 M | -4.78 M | -4.77 M | -9.55 M | -3.73 M | -3.19 M | -2.64 M | -3.15 M | -2.64 M | -2.06 M | -1.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
5.79 M | - | 4.14 M | 6.93 M | 5.87 M | - | 4.4 M | 5.62 M | 4.58 M | 10.2 M | 3.51 M | 4.86 M | 4.82 M | 9.68 M | 3.79 M | 3.26 M | 2.74 M | 3.26 M | 2.74 M | 2.19 M | 1.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.21 M | - | 1.58 M | 1.82 M | 1.55 M | - | 1.23 M | 1.86 M | 1.92 M | 3.78 M | 1.34 M | 1.71 M | 2.04 M | 3.76 M | 1.03 M | 2.11 M | 1.84 M | 2.11 M | 1.84 M | 1.9 M | 750 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency